Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Erectile dysfunction and hypogonadism. Is routine endocrine screening necessary?]

J Noldus1, H Huland

  • 1Urologische Universitätsklinik Hamburg-Eppendorf.

Der Urologe. Ausg. A
|January 1, 1994
PubMed
Summary

Hypogonadism rarely causes erectile dysfunction. Endocrine screening for impotence is recommended only for men with low testosterone or decreased libido, not all patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Early cystectomy-patient selection and technique].

Der Urologe. Ausg. A·2021
Same author

[Quality assessment of radical cystectomy-opportunities, risks, challenges].

Der Urologe. Ausg. A·2021
Same author

[Quality criteria in urology : How to obtain comparable results?]

Der Urologe. Ausg. A·2021
Same author

[Radical cystectomy and urinary diversion-what is important ?]

Der Urologe. Ausg. A·2018
Same author

Early clinical experience with water-jet dissection (hydro-jet) during nerve-sparing radical retropubic prostatectomy.

Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy·2017
Same author

[When is surgical resection of the primary tumor indicated in metastatic prostate cancer and what is the scientific rationale?]

Der Urologe. Ausg. A·2017

Area of Science:

  • Endocrinology
  • Urology
  • Men's Health

Context:

  • Erectile dysfunction (ED) is a common concern, often evaluated for hormonal imbalances.
  • Hypogonadism, characterized by insufficient testosterone production, is infrequently the primary cause of ED.
  • Distinguishing between primary and secondary hypogonadism is crucial for appropriate management.

Purpose:

  • To assess the prevalence of endocrinopathy, specifically hypogonadism, in men presenting with erectile dysfunction.
  • To clarify the indications for endocrine screening and testosterone replacement therapy in patients with ED.

Summary:

  • A study of 70 men treated for impotence revealed a 4.3% rate of endocrinopathy.
  • Testosterone replacement therapy is beneficial primarily for patients with confirmed low serum testosterone and diminished libido.

Related Experiment Videos

  • Endocrine evaluation is indicated for impotent men exhibiting clinical signs of hypogonadism or those with decreased libido, irrespective of other signs.

    • Impact:

    • Highlights the limited role of hypogonadism as a cause for erectile dysfunction.
    • Guides clinicians on selective endocrine screening, avoiding unnecessary and costly tests for all ED patients.
    • Emphasizes targeted testosterone therapy for specific patient subgroups, optimizing treatment efficacy.